[
  {
    "ts": null,
    "headline": "Raising the Voices of Children with Rare Diseases: Ayla's Story",
    "summary": "Any parent can relate to the stress of having a sick child. But when a child is diagnosed with a rare disease, it flips a family's world upside down and sets them down an often fruitless and...",
    "url": "https://finnhub.io/api/news?id=0c9d7d63cf6214fbdb9fb73b331fb390897428258972f33c11ed92ba9091ca48",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740735677,
      "headline": "Raising the Voices of Children with Rare Diseases: Ayla's Story",
      "id": 132905705,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Any parent can relate to the stress of having a sick child. But when a child is diagnosed with a rare disease, it flips a family's world upside down and sets them down an often fruitless and...",
      "url": "https://finnhub.io/api/news?id=0c9d7d63cf6214fbdb9fb73b331fb390897428258972f33c11ed92ba9091ca48"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740726000,
      "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "id": 132907806,
      "image": "",
      "related": "MRNA",
      "source": "DowJones",
      "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8"
    }
  },
  {
    "ts": null,
    "headline": "UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older",
    "summary": "Britain's health regulator said onFriday it has approved Moderna's vaccine forrespiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the...",
    "url": "https://finnhub.io/api/news?id=188466301ea114196d32062d6a407f1a87721e20bfa1f9d1279c095266ea954a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740722878,
      "headline": "UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older",
      "id": 132904311,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Britain's health regulator said onFriday it has approved Moderna's vaccine forrespiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the...",
      "url": "https://finnhub.io/api/news?id=188466301ea114196d32062d6a407f1a87721e20bfa1f9d1279c095266ea954a"
    }
  },
  {
    "ts": null,
    "headline": "UK health regulator approves Moderna's RSV vaccine for people aged 60 and over",
    "summary": "Britain's health regulator said on Friday it has approved Moderna's vaccine to protect patients aged 60 and over against lower respiratory tract disease caused by the respiratory syncytial virus . ...",
    "url": "https://finnhub.io/api/news?id=bb7073a55a52e366e63ee348f4b6320d51517cbdebf33d27d2ab1f8e94fc7d24",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740721882,
      "headline": "UK health regulator approves Moderna's RSV vaccine for people aged 60 and over",
      "id": 132904251,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Britain's health regulator said on Friday it has approved Moderna's vaccine to protect patients aged 60 and over against lower respiratory tract disease caused by the respiratory syncytial virus . ...",
      "url": "https://finnhub.io/api/news?id=bb7073a55a52e366e63ee348f4b6320d51517cbdebf33d27d2ab1f8e94fc7d24"
    }
  }
]